Fig. 1From: Soluble neprilysin and long-term clinical outcomes in patients with coronary artery disease undergoing percutaneous coronary intervention: a retrospective cohort studyComparison of soluble neprilysin levels. a Left ventricular ejection fraction (b) smoking (c) all-cause death (d) major adverse cardiovascular eventsBack to article page